LeMaitre Vascular, Inc. (NASDAQ: LMAT) reported Q2 EPS of $0.08, $0.03 better than the analyst estimate of $0.05. Revenue for the quarter came in at $18.2 million versus the consensus estimate of $17.5 million.

For earnings history and earnings-related data on LeMaitre Vascular, Inc. (LMAT) click here.